TMCnet News
Global Castration Resistant Prostate Cancer Treatment Market 2017-2021 with Astellas Pharma, Johnson & Johnson, Sanofi & Valeant Dominating - Research and MarketsThe "Global Castration Resistant Prostate Cancer Treatment Market 2017-2021" report has been added to Research and Markets' offering. The global castration-resistant prostate cancer treatment market to grow at a CAGR of 9.01% during the period 2017-2021. Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers sales of branded, generic, and off-label drugs. One trend in the market is increasing consolidation in cancer treatment market. The oncology drugs industry has seen significant R&D and funding, which are largely responsible for the increasing consolidation of the industry. The rising trend of movement of cancer treatment from clinics to hospitals signifies the growing importance of strategic alliances and acquisition among the vendors. According to the report, one driver in the market is physician's preerence toward hormonal therapy. The abnormal growth in testosterone level characterizes prostate cancer. Therefore, hormone therapies, which control the secretion of this hormone and help reduce the growth of prostate cancer cells, remain the most sought-after therapy for treating CRPC. The proven efficacious profiles of these therapies with established clinical credentials have led to increased adoption among physicians. Hormonal therapies dominate the global CRPC treatment market and are expected to continue with the same during the forecast period. Key vendors
Other prominent vendors
Key Topics Covered: Part 01: Executive summary Part 02: Scope of the report Part 03: Research Methodology Part 04: Introduction Part 05: Market landscape Part 06: Pipeline landscape Part 07: Market segmentation by therapy Part 08: Geographical segmentation Part 09: Decision framework Part 10: Drivers and challenges Part 11: Market trends Part 12: Vendor landscape Part 13: Key vendor analysis Part 14: Appendix For more information about this report visit https://www.researchandmarkets.com/research/296z6g/global_castration
View source version on businesswire.com: http://www.businesswire.com/news/home/20170721005255/en/ |
